CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x September 30, 2010

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2010-11-10
Original SEC Filing: Click here


Webplus: CPHI/20101110/10-Q/1/000.htm SEC Original: cphi10q093010.htm
FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)




Webplus: CPHI/20101110/10-Q/2_EX-10.1/000.htm SEC Original: cphi10qex101093010.htm
Hainan Helpson Medical & Biotechnology Long-term Laborntract Employer:Hainan Helpson Medical & Biotechnology (hereunderlled Party A ormpany) Zhilin Li Legal Representative/ authorisedent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A’sdress: 570216 Postde: Zhilin Li (hereunderlled Party B)




Webplus: CPHI/20101110/10-Q/3_EX-31.1/000.htm SEC Original: cphi10qex311093010.htm
CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such




Webplus: CPHI/20101110/10-Q/4_EX-31.2/000.htm SEC Original: cphi10qex312093010.htm
CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such




Webplus: CPHI/20101110/10-Q/5_EX-32.1/000.htm SEC Original: cphi10qex321093010.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 ——————————– President and Chief Executive Officer cphi10qex321093010.htm 5 EX-32.1




Webplus: CPHI/20101110/10-Q/6_EX-32.2/000.htm SEC Original: cphi10qex322093010.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 ——————— (principal financial officer and principal accounting officer) cphi10qex322093010.htm 6 EX-32.2



Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2010-11-10CIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216

Home Page Forums

By | 2016-02-07T23:23:50+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar